Eli Lilly and Company Joins cTAP Marathon Pharmaceuticals and Italfarmaco Join cTAP 2017 IRDiRC Abstract – Translating Natural History into Clinical Trial Design Translating Natural History into Clinical Trial Design – lessons from Duchenne Muscular Dystrophy View the Full PDF
